Linked hypotheses (20)

• LIMKi3 × CHRNG_fetal affinity via computational screening (Boltz-2)
  mechanismconf 88%
• LIMKi3 binds CHRNG_fetal (Boltz-2 iPTM=0.884)
  targetconf 88%
• MuSK_chembl_1 binds CHRNG_fetal (Boltz-2 iPTM=0.816)
  targetconf 82%
• MuSK_chembl_1 × CHRNG_fetal affinity via computational screening (Boltz-2)
  mechanismconf 80%
• MuSK_chembl_1 binds CHRNG_fetal (Boltz-2 iPTM=0.803)
  targetconf 80%
• Off-target candidate: **ataluren** → CHRNG (iPTM=0.766)
  mechanismconf 77%
• ataluren off-target binding to CHRNG
  repurposingconf 77%
• LIMKi3 × CHRNG_fetal affinity via computational screening (Boltz-2)
  mechanismconf 77%
• LIMKi3 binds CHRNG_fetal (Boltz-2 iPTM=0.774)
  targetconf 77%
• riluzole × CHRNG_fetal affinity via computational screening (Boltz-2)
  repurposingconf 76%
• riluzole binds CHRNG_fetal (Boltz-2 iPTM=0.761)
  targetconf 76%
• curcumin × CHRNG_fetal affinity via computational screening (Boltz-2)
  mechanismconf 73%
• curcumin binds CHRNG_fetal (Boltz-2 iPTM=0.735)
  targetconf 73%
• haloperidol × CHRNG_fetal affinity via computational screening (Boltz-2)
  repurposingconf 73%
• haloperidol binds CHRNG_fetal (Boltz-2 iPTM=0.735)
  targetconf 73%
• PAK4_chembl_1 × CHRNG_fetal affinity via computational screening (Boltz-2)
  mechanismconf 73%
• PAK4_chembl_1 binds CHRNG_fetal (Boltz-2 iPTM=0.733)
  targetconf 73%
• ataluren off-target binding to CHRNG
  repurposingconf 71%
• Off-target candidate: **ataluren** → CHRNG (iPTM=0.711)
  mechanismconf 71%
• Off-target candidate: **riluzole** → CHRNG (iPTM=0.702)
  mechanismconf 70%

Top compound hits (0)

No ranked compounds yet for CHRNG.

Linked claims (30)